"Kory and eight coauthors published a paper on the results, which showed “regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.”
Those who used ivermectin had a 44% reduction in COVID-19 infection rate, a 68% reduction in COVID-19 mortality and a 56% reduction in hospitalization rate compared to those who did not."
